Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of a Multiomics Assay for Use on OriColTM Sampled Rectal Mucus for Detection of Cancer and Significant Polyps in Symptomatic Patients on the Colorectal Urgent Suspected Cancer Pathway

NCT06649123 is registered in ClinicalTrials.gov with Origin Sciences as lead sponsor.

NCT NCT06649123
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06649123 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of a Multiomics Assay for Use on OriColTM Sampled Rectal Mucus for Detection of Cancer and Significant Polyps in Symptomatic Patients on the Colorectal Urgent Suspected Cancer Pathway
Lead sponsor
Origin Sciences
Phase
Observational
Overall status
Recruiting
Start date
November 1, 2024
Completion date
April 1, 2027
Enrollment
6,600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adenoma colon polyp, colorectal cancer